Chloromethane

Chloromethane

SCHEMBL1334446

CCl.CN(C)C=CC(N)=O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.56
MAPT P10636 6/20 0.41
HPGD P15428 3/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
ALOX12 P18054 1/20 0.41
RECQL P46063 2/20 0.39
ALDH1A1 P00352 6/20 0.37
HTT P42858 3/20 0.37
LMNA P02545 3/20 0.37
RAB9A P51151 2/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 1/20 0.34
KMT2A Q03164 2/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL158198 0.95
SCHEMBL2043304 0.95
Ammonia Solution, Strong SCHEMBL7051918 0.92
Chloromethane SCHEMBL8972585 0.76 TDP1 (0.58) TDP1MAPTHPGDCYP1A2CYP2C19
SCHEMBL9605455 0.75 TDP1 (0.32) TDP1
SCHEMBL6822956 0.74 TDP1 (0.50) TDP1MAPTHPGDCYP1A2CYP2C19
SCHEMBL6822957 0.74 TDP1 (0.50) TDP1MAPTHPGDCYP1A2CYP2C19
SCHEMBL7713853 0.72
SCHEMBL7713849 0.72
SCHEMBL19182708 0.72 TDP1 (1.00) TDP1MAPTHPGDCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8753686-B2 Surface-treating agents, surface-treated powders, and cosmetics comprising the same SHISEIDO CO., LTD. (JP) 2014-06-17 US disclosed
US-20110280946-A1 Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same SHISEIDO CO., LTD. (JP) 2011-11-17 US disclosed
EP-2112179-B1 Surface-treated powders, and cosmetics comprising the same SHISEIDO CO LTD (JP) 2011-04-27 EP disclosed
EP-1803750-B1 USE OF A POLYMER FOR SURFACE-TREATING A POWDER SHISEIDO CO LTD (JP) 2009-12-09 EP disclosed
EP-2112179-A1 Surface-treated powders, and cosmetics comprising the same Shiseido Co., Ltd. (JP) 2009-10-28 EP disclosed
US-20080081029-A1 acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability SHISEIDO CO., LTD. (JP) 2008-04-03 US disclosed
EP-1803750-A1 SURFACE-TREATING AGENT, SURFACE-TREATED POWDER, AND COSMETIC PREPARATION CONTAINING SAME Shiseido Company, Limited (JP) 2007-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081029-A1 acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability CHRM1, H1-0, H1-2 TDP1 856/4885MAPT 4314/4885HPGD 1891/4885
US-20110280946-A1 Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same CHRM1, H1-0, H1-2 TDP1 781/4885MAPT 2431/4885HPGD 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.